Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders [NA]
This clinical trial from Karolinska Institutet compares metacognitive therapy to a unified protocol for patients with comorbid anxiety disor…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia [NA]
A completed Penn State trial evaluated virtual reality exposure therapy scripts for social anxiety disorder and has posted results.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Cross-Cultural Differences in the Network Structure of Social Anxiety and Body Dysmorphic Symptoms
A completed clinical trial update examining cross-cultural differences in the network structure of social anxiety and body dysmorphic sympto…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth [NA]
A Florida International University study aims to reduce social anxiety in youth by training attention to social threat; the trial is current…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Targeting Social Function in Anxiety and Eating Disorders [NA]
University of Texas Southwestern Medical Center is recruiting a trial aimed at improving social functioning in people with anxiety and eatin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-23FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial [NA]
A multicenter randomized trial evaluating primary care behavioral health with added self-help CBT is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder [NA]
Completed clinical trial evaluating oVRcome, a self-guided virtual reality intervention for Social Anxiety Disorder, conducted by the Univer…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation [NA]
A clinical trial evaluating trigeminal nerve stimulation for anxiety disorders is currently active but not recruiting. The conditions includ…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Optimizing Exposure Therapy for Anxiety Disorders [NA]
A UCLA-sponsored clinical trial evaluating exposure therapy optimization for social anxiety disorder and panic disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression [NA]
This clinical trial is recruiting adolescents to evaluate a transdiagnostic internet-delivered intervention for anxiety and depressive disor…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: The Covideo Study - a Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delivery [NA]
A clinical trial evaluating cognitive therapy for social anxiety disorder in youth, comparing remote screen-delivered delivery to traditiona…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder [Phase 2]
A Phase 2 trial evaluating BNC210 for acute treatment of Social Anxiety Disorder has completed and results have been posted.
-
FDA approval · 2025-03-13FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) as a generic product under NorthStar Rx LLC's ANDA.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. [NA]
A completed randomized study evaluating two at-home self-guided virtual reality interventions for adults with Social Anxiety Disorder, with …
-
FDA approval · 2025-02-28FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited, adding regulatory approval for this ge…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Text Message Safety Behavior Fading for Social Anxiety [NA]
This clinical trial update reports that a study evaluating text message safety behavior fading for social anxiety disorder has completed.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety [NA]
ClinicalTrials.gov update describes an ongoing Boston University study examining neural markers of treatment mechanisms and predicting treat…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Partners in Caring for Anxious Youth [Phase 3]
An update on a Phase 3 clinical trial for anxious youth, currently active but not recruiting.
-
FDA approval · 2025-02-15FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Sertraline Hydrochloride from XLCare Pharmaceuticals, Inc., authorizing the generic product.
-
FDA approval · 2025-02-11FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine (Padagis US LLC), updating the labeling to reflect expanded indications for the antid…
-
FDA approval · 2025-01-29FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline), authorizing the generic prod…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Evaluating Clinical Routines for ICBT [NA]
Update on a clinical trial evaluating internet-delivered cognitive behavioral therapy (ICBT) for depression, panic disorder, and social anxi…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD [NA]
This trial result updates the completion and posting of results for a parent-led cognitive-behavioral teletherapy intervention targeting anx…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder [NA]
This clinical trial update reports results for a parent-based treatment approach for youth with obsessive-compulsive disorder and other anxi…